Free Trial
OTCMKTS:TLOG

TetraLogic Pharmaceuticals (TLOG) Stock Price, News & Analysis

TetraLogic Pharmaceuticals logo

About TetraLogic Pharmaceuticals Stock (OTCMKTS:TLOG)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$2,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Receive TLOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TetraLogic Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TLOG Stock News Headlines

TetraLogic Pharmaceuticals Corporation (TLOG)
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
See More Headlines

TLOG Stock Analysis - Frequently Asked Questions

Shares of TLOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that TetraLogic Pharmaceuticals investors own include Bristol-Myers Squibb (BMY), Trevena (TRVN), Vaxart (VXRT), Arrowhead Pharmaceuticals (ARWR), Sangamo Therapeutics (SGMO), Achieve Life Sciences (ACHV) and Gilead Sciences (GILD).

Company Calendar

Today
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:TLOG
Previous Symbol
NASDAQ:TLOG
Employees
29
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
20,570,000
Market Cap
$2,000.00
Optionable
Not Optionable
Beta
2.86
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (OTCMKTS:TLOG) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners